Literature DB >> 20433226

Reliability and validity of the Bipolar Depression Rating Scale on an Iranian sample.

Amir Shabani1, Mehdi Akbari, Mohsen Dadashi.   

Abstract

BACKGROUND: The Bipolar Depression Rating Scale is an instrument to measure depression severity in patients diagnosed with bipolar disorder. This study has reevaluated the psychometric values of the Bipolar Depression Rating Scale through assessing an Iranian sample of patients with bipolar depression.
METHODS: A total of 60 patients (36 males and 24 females) with bipolar depression referred to four medical centers in Tehran, Iran were interviewed with the Structured Clinical Interview for DSM-IV axis I Disorders, Young Mania Rating Scale, center for Epidemiological Studies Depression Scale, and the Bipolar Depression Rating Scale. Internal consistency and inter-rater reliability of the Bipolar Depression Rating Scale, and Pearson's correlation coefficient between the Bipolar Depression Rating Scale and Young Mania Rating Scale/Center for Epidemiological Studies Depression Scale were calculated.
RESULTS: The Cronbach's alpha coefficient was 0.81. The Pearson's correlation coefficients of the Bipolar Depression Rating Scale with the Center for Epidemiological Studies Depression Scale and Young Mania Rating Scale were 0.73 and -0.82, respectively. The correlation coefficients between the two raters for the total score of the Bipolar Depression Rating Scale according to the Pearson's correlation and intraclass correlation tests were 0.83 and 0.89, respectively.
CONCLUSION: The Bipolar Depression Rating Scale is a reliable and valid instrument to use in studies on Iranian clinical patients with bipolar depression.

Entities:  

Mesh:

Year:  2010        PMID: 20433226

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  6 in total

1.  Quality of life in Iranian patients with bipolar disorder: a psychometric study of the Persian Brief Quality of Life in Bipolar Disorder (QoL.BD).

Authors:  Amirhossein Modabbernia; Mohammadhossein Yaghoubidoust; Chung-Ying Lin; Bengt Fridlund; Erin E Michalak; Greg Murray; Amir H Pakpour
Journal:  Qual Life Res       Date:  2015-12-29       Impact factor: 4.147

2.  Relationship between depression and apolipoproteins A and B: a case-control study.

Authors:  Masoumeh Sadeghi; Hamidreza Roohafza; Hamid Afshar; Fereshteh Rajabi; Mohamadarash Ramzani; Hasan Shemirani; Nizal Sarafzadeghan
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS).

Authors:  Young-Eun Jung; Moon-Doo Kim; Won-Myong Bahk; Young Sup Woo; Jonghun Lee; Sae-Heon Jang; Seunghee Won; Kyung Joon Min; Sangkeun Chung; Young-Joon Kwon; Duk-In Jon; Kwanghun Lee; Bo-Hyun Yoon
Journal:  BMC Psychiatry       Date:  2016-07-15       Impact factor: 3.630

4.  Feasibility of the Korean version of the Bipolar Depression Rating Scale in Adolescents with Early-Onset Bipolar Disorder.

Authors:  Da-Young Lee; Eun-Kyung Won; Jung-Won Choi; Hye Ji Min; Jayoun Kim; Kyooseob Ha; Yunglyul Lee; Jae Seung Chang; Yeni Kim
Journal:  Psychiatry Investig       Date:  2017-09-11       Impact factor: 2.505

5.  Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder.

Authors:  Jing-Xu Chen; Lu Yin; Hai-Ting Xu; Suo-Yuan Zhang; Wen-Qian Huang; Hong-Juan Li; Bin-Bin Li; Ke-Bing Yang; Qian Li; Michael Berk; Yun-Ai Su
Journal:  Neuropsychiatr Dis Treat       Date:  2021-03-12       Impact factor: 2.570

6.  Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale.

Authors:  Mohammad Ahmadpanah; Meisam Sheikhbabaei; Mohammad Haghighi; Fatemeh Roham; Leila Jahangard; Amineh Akhondi; Dena Sadeghi Bahmani; Hafez Bajoghli; Edith Holsboer-Trachsler; Serge Brand
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-07       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.